argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)- has been researched along with argipressin, deaminopenicillamine(1)-val(4)- in 1 studies
Studies (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Trials (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Recent Studies (post-2010) (argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)-) | Studies (argipressin, deaminopenicillamine(1)-val(4)-) | Trials (argipressin, deaminopenicillamine(1)-val(4)-) | Recent Studies (post-2010) (argipressin, deaminopenicillamine(1)-val(4)-) |
---|---|---|---|---|---|
33 | 0 | 0 | 13 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bemana, I; Kagawa, M; Nagao, S | 1 |
1 other study(ies) available for argipressin, beta-mercapto-beta,beta cyclopentamethylenepropionic acid(1)- and argipressin, deaminopenicillamine(1)-val(4)-
Article | Year |
---|---|
Arginine vasopressin receptor antagonists for treatment of vasogenic brain edema: an experimental study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Body Water; Brain Chemistry; Brain Edema; Cardiovascular Agents; Cerebrovascular Disorders; Cold Temperature; Injections, Intraventricular; Male; Rats; Rats, Sprague-Dawley | 1996 |